Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area
Rosales-Klintz, S., Bruchfeld, J., Haas, W., Heldal, E., Houben, R.M.G.J., van Kessel, F., Mandelbaum, M., Matteelli, A., Migliori, G.B., Oordt-Speets, A., Solovic, I., Vašáková, M., Verver, S., de Vlas, S.J., Vonk Noordegraaf-Schouten, M.J.M., de Vries, G., Zenner, D., van der Werf, M.J.
Programmatic management of latent tuberculosis infection in the European Union
Programmatic management of latent tuberculosis infection (LTBI) is a key component of the global tuberculosis (TB) elimination strategy. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area (EU/EEA).
Review of reviews and guidelines on target groups, diagnosis, treatment and programmatic issues for implementation of latent tuberculosis management
This report is part of a series of technical documents describing the collection, synthesis and appraisal of the available information on specific measures for the prevention, identification and treatment of LTBI, analysed from the perspective of national TB-control programmes.
Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA
The elimination of tuberculosis (TB) in Europe will require the management of latent tuberculosis infection (LTBI) in key populations. Management of LTBI requires the identification and adequate treatment of infected people. It is currently unknown how screening and treatment of key populations should be best organised to have the highest impact with the available resources.